PB1926: REAL-WORLD ERYTHROPOIESIS-STIMULATING AGENT (ESA) TREATMENT PATTERNS AND OUTCOMES AMONG US PATIENTS WITH LOWER-RISK MYELODYSPLASTIC SYNDROMES (LR-MDS)
oleh: S. Mukherjee, K. Zimmerman Savill, A. Gajra, J. Kish, C. Brown-Bickerstaff, D. Gentile, A. Falkenstein, T. Miller, J. Laney, A. McBride
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2022-06-01 |
Deskripsi
No description available for this item.